Fibromuscular dysplasia risk factors: Difference between revisions
(Created page with "__NOTOC__ {{Fibromuscular dysplasia}} {{CMG}}; '''Associate Editor-in-Chief:''' Shantanu Sinha, MD,FACC ==Overview== ==Risk Factors== *Sex. Women have a much greater risk t...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Fibromuscular dysplasia}} | {{Fibromuscular dysplasia}} | ||
{{CMG}}; | {{CMG}}; {{AE}} | ||
==Overview== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
* | *[Condition 1] | ||
* | *[Condition 2] | ||
*[ | *[Condition 3] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: (name of the system)]] | |||
Revision as of 13:00, 25 April 2018
|
Fibromuscular dysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ASA/ACCF/AHA Guideline Recommendations |
|
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
|
Case Studies |
|
Fibromuscular dysplasia risk factors On the Web |
|
American Roentgen Ray Society Images of Fibromuscular dysplasia risk factors |
|
Risk calculators and risk factors for Fibromuscular dysplasia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]